Previous studies have shown that tetraploid (4n) cells rarely contribute to the derivatives of the epiblast lineage of mid-gestation 4n42n mouse chimeras. The aim of the present study was to determine when and how 4n cells were excluded from the epiblast lineage of such chimeras. The contributions of GFP-positive cells to different tissues of 4n42n chimeric blastocysts labelled with tauGFP were analysed at E3.5 and E4.5 using confocal microscopy. More advanced E5.5 and E7.5 chimeric blastocysts were analysed after a period of diapause to allow further growth without implantation. Tetraploid cells were not initially excluded from the epiblast in 4n42n chimeric blastocysts and they contributed to all four blastocyst tissues at all of the blastocyst stages examined. Four steps affected the allocation and fate of 4n cells in chimeras, resulting in their exclusion from the epiblast lineage by mid-gestation. (1) Fewer 4n cells were allocated to the inner cell mass than trophectoderm. (2) The blastocyst cavity tended to form among the 4n cells, causing more 4n cells to be allocated to the hypoblast and mural trophectoderm than the epiblast and polar trophectoderm, respectively. (3) 4n cells were depleted from the hypoblast and mural trophectoderm, where initially they were relatively enriched. (4) After implantation 4n cells must be lost preferentially from the epiblast lineage. Relevance of these results to the aetiology of human confined placental mosaicism and possible implications for the interpretation of mouse tetraploid complementation studies of the site of gene action are discussed. q
Introduction
Four distinct cell lineages are established by the late blastocyst stage in the mouse. The formation of the fluid-filled blastocyst cavity (blastocoel) marks the transition from the morula to the early blastocyst stage at embryonic day (E) 3.5. At this stage an outer layer of trophectoderm (TE) surrounds the inner cell mass (ICM) and blastocyst cavity. In the mouse the TE overlying the ICM is known as the polar trophectoderm (pTE) and this proliferates to form the chorionic ectoderm and placental trophoblast. The TE surrounding the blastocyst cavity is known as the mural trophectoderm (mTE) and this quickly stops proliferating and forms only the primary trophoblast giant cells, so this lineage contributes little to the mid-gestation conceptus. At the late blastocyst stage (E4.5), the ICM divides into the epiblast (also known as primitive ectoderm) and the hypoblast (or primitive endoderm). The epiblast produces the entire fetus, the amniotic ectoderm plus the extraembryonic mesoderm of the amnion, allantois, visceral yolk sac and chorion. We use the term 'hypoblast' as an alternative to the term 'primitive endoderm' and this tissue produces the endoderm layer of the visceral yolk sac and the parietal endoderm associated with Reichert's membrane. Thus, by E4.5 the epiblast, hypoblast, pTE and mTE have been established as four distinct developmental lineages. The hypoblast and mTE surround the blastocyst cavity and so occupy the abembryonic pole whereas the epiblast and pTE occupy the embryonic pole of the blastocyst.
Mouse tetraploid4diploid (4n42n) chimeras and 4n/2n mosaics usually show a restricted tissue distribution, with 4n cells excluded from the epiblast lineage by mid-gestation (Tarkowski et al., 1977; Nagy et al., 1990; James et al., 1995; Goto et al., 2002) . In some 4n42n chimeras, 4n cells have contributed to the epiblast derivatives after mid-gestation but this is uncommon unless the aggregated 4n and 2n embryos differ significantly in age or a high proportion of 4n cells is used to produce the chimera (Section 3). The restricted distribution of 4n cells in chimeras has been exploited experimentally, both to enable the direct production of mice from embryonic stem (ES) cells (Nagy et al., 1990; and for tetraploid complementation investigations of the site of gene action.
In tetraploid complementation experiments, chimeras are made by combining wildtype 4n embryos with 2n embryos, which have a lethal mutant genotype, and this can help determine whether gene action is required in the epiblast or only in the trophectoderm and/or hypoblast. In a 2n mutant44n wildtype chimera, the fetus will be entirely mutant (2n) but may be supported by a substantial contribution of wildtype cells (4n) in the extraembryonic tissues derived from the trophectoderm and/or hypoblast. If such a mutant fetus survives this indicates that action of this gene is not required in the epiblast for fetal survival. This elegant tetraploid complementation approach is becoming widely used and has already proved useful for the analysis of the site of action of many genes. Initial studies in the 1990s included analysis of Ascl2 (previously Mash2), achaete-scute complex homolog-like 2 (Drosophila) (Guillemot et al., 1994) , Hnf4a (previously Hnf-4), hepatic nuclear factor 4, alpha (Duncan et al., 1997) , Smad4, MAD homolog 4 (Drosophila) (Sirard et al., 1998) and Pparg, peroxisome proliferator activated receptor gamma (Barak et al., 1999) . The use of this approach is growing rapidly and more recent studies include Bmp4, bone morphogenetic protein 4 (Fujiwara et al., 2002) , Snx1 and Snx2, sorting nexins 1 and 2 (Schwarz et al., 2002) , Eed, embryonic ectoderm development (Wang et al., 2002) , Socs3, suppressor of cytokine signaling 3 (Takahashi et al., 2003) Rb1 (also known as Rb), retinoblastoma (Wu et al., 2003) , tcl w5 (previously t w5 ), t-complex lethal w5 (Sugimoto et al., 2003) , Flt1, fms-like tyrosine kinase 1 (Hirashima et al., 2003) , Mapk1 mitogen activated protein kinase 1 (previously Erk2, extracellular signal-regulated kinase 2) (Hatano et al., 2003) , Esrrb (also known as Estrrb) estrogen related receptor, beta (Mitsunaga et al., 2004) , Chm, choiroderemia (Shi et al., 2004) , Cdx2, caudal type homeobox 2 (Chawengsaksophak et al., 2004) , Gata4, GATA binding protein 4 (Watt et al., 2004) and Gata6, GATA binding protein 6 (Zhao et al., 2005) .
The exclusion of tetraploid cells from the fetus in 4n42n chimeras also provides a useful model of type I human confined placental mosaicism (CPM). This is a clinically significant condition where chromosomally abnormal cells are confined to the cytotrophoblast and are not present in the fetus or other epiblast derivatives (Kalousek and Vekemans, 1996; Wolstenholme, 1996) . Eakin and Behringer (2003) have reviewed other aspects of the development of tetraploid mice and 4n42n chimeras.
Previous studies of E12.5 mid-gestation mouse 4n42n chimeras revealed that 4n cells rarely contribute to any tissues of the epiblast lineage but are frequently present in the hypoblast and trophectoderm lineages (James et al., 1995; Goto et al., 2002) . Although this restricted distribution of 4n cells in 4n42n mouse chimeras has proved useful in several ways, it is not yet known how 4n cells become excluded from the epiblast lineage. Fig. 1 shows three hypotheses, which could each explain how this occurs. The first hypothesis is that 4n cells are excluded from the epiblast region when it first differentiates within the inner cell mass of blastocyst stage 4n42n chimeric embryos. Consequently 4n cells never contribute to derivatives of the epiblast lineage. The second hypothesis is that 4n cells contribute equally to all lineages at the late blastocyst stage but they are subsequently lost specifically from the epiblast derivatives. Tetraploid cells are, therefore, excluded from the epiblast lineage by mid-gestation but frequently retained in the hypoblast and trophectoderm derivatives. The third hypothesis represents a combination of the first two and proposes that 4n cells are already depleted but not excluded from the epiblast at the late blastocyst stage. The depletion of 4n cells continues in the epiblast derivatives and they are excluded from this lineage by mid-gestation.
To distinguish between these three hypotheses we need to know whether 4n cells are initially present in the epiblast at the blastocyst stage (hypotheses 2 and 3), if so whether they are present at normal levels (hypothesis 2) and whether selection against 4n cells occurs in the epiblast lineage (hypotheses 2 and 3).
Previous analyses of 4n42n chimeric mouse blastocysts, using DNA in situ hybridisation to a reiterated b-globin transgene, showed that 4n cells contributed to both the ICM and TE but they contributed more to the TE, specifically the mTE, at E3.5 and then were depleted between E3.5 and E4.5 (Everett and West, 1996; Tang et al., 2000) . These histological, in situ hybridisation studies showed that tetraploid cells were present in the ICM of 4n42n chimeric blastocysts and suggested there was a generalised selection against 4n cells but, for technical reasons, it was not possible to determine if 4n cells were present in the epiblast as well as the hypoblast (Everett and West, 1998) . Tetraploid cells also contributed to both the ICM and TE of 4n42n chimeric rhesus monkey blastocysts (Schramm and Paprocki, 2004) .
While James et al. (1995) ; Goto et al. (2002) agreed that, in mouse chimeras, 4n cells rarely contributed to the epiblast derivatives at E12.5 their results differed for E7.5. James et al. (1995) reported that 4n cells were usually absent from the epiblast derivatives at both E7.5 and E12.5 whereas Goto et al. (2002) found 4n cells were commonly present at E7.5, albeit at a low level. The results of Goto et al. (2002) suggest that 4n cells are present in the epiblast and survive until approximately E7.5 but not to E12.5. If this is confirmed this would refute hypothesis 1 but it does not distinguish between hypotheses 2 and 3.
The present study was designed to distinguish between the three hypotheses shown in Fig. 1 . Confocal microscopy was used to analyse the contributions of GFP-positive cells to different tissues of living 4n42n chimeric blastocysts marked with the TgTP6.3 transgene. This transgene produces a tauGFP fusion protein between green fluorescent protein and the microtubule protein tau. Hemizygous TgTP6.3 C/K embryos express tauGFP ubiquitously by the late 2-cell stage and this has been shown to be an excellent marker for studies with preimplantation embryos (Pratt et al., 2000; MacKay et al., 2005) .
Results
Two separate series of 4n42n (4nGFP42n and 4n42nGFP) and control 2nGFP42n chimeric blastocysts were cultured in vitro and analysed at E3.5 and E4.5 to determine if 4n cells in the ICM were preferentially allocated to the hypoblast. The E3.5 series was also analysed to determine the position of the blastocyst cavity relative to the distribution of 4n and 2n cells soon after cavity formation. It was often difficult to distinguish the epiblast and hypoblast clearly at E3.5 and E4.5 but they were defined as described in Section 4 and shown in Fig. 2 . More advanced chimeric blastocysts were also produced by transferring E3.5 chimeras to pseudopregnant females, injected with the anti-oestrogen tamoxifen to induce diapause. 4nGFP42n and control 2nGFP42n were analysed at E5.5 and E7.5, to test whether 4n cells were present within the epiblast and hypoblast regions, after these tissues had already differentiated. Three series of chimeras were produced and cultured in vitro: 2nGFP42n control chimeras, 4nGFP42n experimental chimeras and the reciprocal combination of 4n42nGFP experimental chimeras. Chimeric blastocysts were imaged by confocal microscopy at E3.5 and E4.5 to determine whether 4n cells contributed to the epiblast (Fig. 3A-D) . The epiblast of most control 2nGFP42n chimeras contained both GFP-positive and GFP-negative cells (20/21 at E3.5 and 6/8 at E4.5). In most experimental chimeras, some 4n cells were present in the presumptive epiblast at E3.5 and the epiblast at E4.5. For 4nGFP42n chimeras, GFP-positive cells were present in 18/23 of E3.5 and 8/11 of E4.5 chimeras. For the reciprocal combination, GFPnegative cells were present in 21/22 of E3.5 and 7/8 of E4.5 4n42nGFP chimeras. The proportion of blastocysts that contained chimeric ICMs, epiblasts or hypoblasts did not vary significantly among the three groups of chimeras analysed at E3.5 or E4.5 (PO0.05 by Fisher's Exact test in each case).
Some experimental 4nGFP42n and control 2nGFP42n chimeric blastocysts were maintained in a state of diapause from E3.5 to E5.5 or E7.5 by transferring them to the uteri of tamoxifen-treated females. Under these conditions cell proliferation continues slowly but the embryo remains as a preimplantation stage blastocyst and is much less advanced than postimplantation embryos at a similar age. This approach was used in order to try to produce embryos with larger ICMs to facilitate identification of the epiblast and hypoblast regions. Confocal images are shown in Fig. 3E-I . The composition of these chimeras varied considerably but showed that 4n cells contributed to the epiblast at both stages analysed.
At E5.5, the epiblasts of 4/7 control 2nGFP42n chimeras contained both GFP-positive and GFP-negative cells (1 was entirely GFP-positive and 2 were entirely GFP-negative). Although GFP-positive cells made no contribution to the epiblasts of 4/7 of the E5.5 4nGFP42n chimeras they contributed well to the other three chimeras. There was no significant difference in the number of blastocysts with chimeric epiblasts between the control and experimental groups (4/7 versus 3/7; Fisher's Exact test PO0.05). There was also no significant difference in the proportion of 4nGFP42n chimeras that had a 4n contribution in the epiblast versus the hypoblast (3/7 versus 4/7; Fisher's Exact test PO0.05).
At E7.5, the epiblasts of 3/5 control 2nGFP42n chimeras contained both GFP-positive and GFP-negative cells (1 was entirely GFP-positive and 1 was entirely GFP-negative). The composition varied among the four experimental 4nGFP42n chimeric blastocysts recovered at E7.5. One blastocyst had a high overall contribution of GFP-positive (4n) cells but the other three chimeras had low proportions of 4n cells, with one blastocyst having only 2n cells in the TE and another having only 2n cells in the ICM. Two blastocysts had a higher percentage of 4n cell contribution to the hypoblast than the epiblast. Despite this variability 4n cells were present in the epiblast of three of the four 4nGFP42n chimeras in diapause at E7.5. There was no significant difference in the proportion of chimeric tissues between epiblasts and hypoblasts for the control or experimental E7.5 chimeras (PO0.05 by Fisher's Exact test), nor was there any significant difference in proportion of chimeric epiblasts or hypoblasts between control and 4nGFP42n blastocysts (PO0.05 by Fisher's Exact test). This implies that 4n cells are frequently present in the epiblasts of E7.5 blastocysts after being in diapause for 4 days.
The qualitative analysis of chimeric blastocysts shows that 4n cells are normally present in the epiblast of cultured E3.5 and E4.5 4n42n chimeric blastocysts and usually remain in the epiblast after being maintained in a state of diapause from E3.5 to E5.5 or from E3.5 to E7.5. This demonstrates that 4n cells are not initially excluded from the epiblast so disproves hypothesis 1 shown in Fig. 1 , leaving hypotheses 2 and 3 as possibilities.
Tetraploid cells are non-randomly allocated to different blastocyst lineages in 4n42n chimeras
The qualitative analysis shows that 4n cells are initially present in the epiblast of 4n42n chimeric blastocysts and previous studies (discussed earlier) have shown that they are absent from this lineage at or before mid-gestation. This means that 4n cells must be lost from the epiblast between the blastocyst stage and mid-gestation as indicated in hypotheses 2 and 3 shown in Fig. 1 . Quantitative analyses of the contributions of 4n cells to the four different lineages of 4n42n chimeric blastocysts were undertaken, as described in Section 4, to investigate the mechanisms that lead to the loss of 4n cells from the epiblast and distinguish between hypotheses 2 and 3. Fig. 4A shows pairwise comparisons of the mean percentage GFP contribution to the individual regions of control 2nGFP42n chimeras (trophectoderm derivatives are shaded darker than ICM-derivatives). The mean contribution of GFPpositive cells was significantly higher in the TE than the ICM, in the mTE than the pTE and in the presumptive hypoblast than the presumptive epiblast (P!0.05 by Mann-Whitney U-test). The small but significant difference in composition of the different tissues of the control 2nGFP42n chimeric blastocysts could reflect genetic differences between the GFP and non-GFP embryos, sample variation or experimental variation attributable to methods used to estimate %GFP composition. To allow for non-random variation, both 4nGFP42n and the reciprocal 4n42nGFP combination were analysed at E3.5 to ensure the trends were consistent ( Fig. 4B-F ).
Fig . 4B shows the contribution of GFP-positive tissue (2n) to different lineages of E3.5 4n42nGFP chimeras. For each of the pairwise comparisons the trends were in the opposite direction to those shown in Fig. 4A for control 2nGFP42n chimeras but only reached statistical significance for mTE versus pTE. For ease of comparison this was converted to the percentage of 4n (GFP-negative) tissue (Fig. 4C ), which shows that the mean 4n contribution was significantly higher in the mTE than the pTE. When the percentage of 4n tissue was converted to the percentage of 4n cells (Fig. 4D ) by taking into account differences in 2n and 4n cell sizes, as described in Section 4, the mean 4n contribution was significantly higher in the TE than the ICM as well as significantly higher in the mTE than the pTE. Fig. 4E shows that for E3.5 4nGFP42n chimeras the contribution of 4n tissue (GFP-positive) was significantly greater in the TE than ICM, greater in the mTE than the pTE and greater in the presumptive hypoblast than the presumptive epiblast. These differences remained statistically significant after the percentage of 4n tissue was converted to the percentage of 4n cells (Fig. 4F) .
The two reciprocal E3.5 4n42n chimera combinations showed the same trends with 4n cells contributing less to the ICM than the TE, less to the pTE than the mTE and less to the presumptive epiblast than the presumptive hypoblast. The trends are more pronounced in the 4nGFP42n chimeras (Fig. 4E,F) than the reciprocal 4n42nGFP chimeras (Fig. 4B-D) and this probably reflects the unequal contribution of GFP- positive cells to different lineages in the E3.5 control 2nGFP42n chimeras (Fig. 4A) . To allow for this, the three pairwise differences were compared between 4n42nGFP and control 2nGFP42n chimeras and between 4nGFP42n and control 2nGFP42n chimeras (Table 1) . Relative to the 2nGFP42n controls, the contribution of GFP-positive tissue in 4n42nGFP chimeras was higher in the ICM than TE, higher in the pTE than mTE and higher in the presumptive epiblast than presumptive hypoblast and these differences were significant for the latter two comparisons. For the reciprocal Results for (a) are from shown in E, as described in text). TE, total trophectoderm; ICM, total inner cell mass; mTE, mural trophectoderm; pTE, polar trophectoderm; Hypo, presumptive hypoblast; Epi, presumptive epiblast. Asterisks indicate significantly different contributions for pairwise comparisons by Mann-Whitney U-tests; *P!0.05; **P! 0.01; ***P!0.001.
4nGFP42n chimeras the contribution of GFP-positive tissue, relative to the 2nGFP42n controls, was lower in the ICM than TE, lower in the pTE than mTE and lower in the presumptive epiblast than presumptive hypoblast and these differences were significant for the first two comparisons. For both 4n42nGFP and 4nGFP42n chimeras this reflects a relative deficiency of 4n cells in the ICM, pTE and presumptive epiblast. The quantitative analyses were repeated for the smaller groups of E4.5 chimeras (Fig. 5 ). Fig. 5A shows pairwise comparisons of the mean percentage GFP contribution to the individual regions of the eight control E4.5 2nGFP42n chimeras. The mean contribution of GFP-positive cells varied among tissues but did not differ significantly for any of the three pairwise comparisons.
The GFP-positive (2n) was analysed in different lineages of eight E4.5 4n42nGFP chimeras (Fig. 5B ), converted to % 4n tissue (Fig. 5C ) and % 4n cells (Fig. 5D) , as described for the E3.5 chimeras. The mean 4n contribution showed the same trends as at E3.5 and was significantly higher in the TE than the ICM and significantly higher in the mTE compared to the pTE (Fig. 5B-D) . The reciprocal E4.5 4nGFP42n chimera combinations followed the pattern shown at E3.5 for the first two pairwise comparisons with 4nGFP cells contributing less to the ICM than the TE and less to the pTE than the mTE (Fig. 5E ). The first difference was significant and remained so after the percentage of 4n tissue was converted to the percentage of 4n cells (Fig. 5F) .
The three E4.5 pairwise differences were compared between 4n42nGFP and control 2nGFP42n chimeras and between 4nGFP42n and control 2nGFP42n chimeras (Table 2) . Relative to the 2nGFP42n controls, the contribution of GFPpositive tissue in 4n42nGFP chimeras was higher in the ICM than TE and higher in the pTE than mTE (as it was at E3.5) but lower in the presumptive epiblast than presumptive hypoblast. None of these differences were statistically significant. For the reciprocal 4nGFP42n chimeras the contribution of shown in E, as described in text). TE, total trophectoderm; ICM, total inner cell mass; mTE, mural trophectoderm; pTE, polar trophectoderm; Hypo, hypoblast; Epi, epiblast. Asterisks indicate significantly different contributions for pairwise comparisons by Mann-Whitney U-tests; *P!0.05; **P!0.01; ***P!0.001.
GFP-positive tissue, relative to the 2nGFP42n controls followed the same pattern seen at E3.5. The 4nGFP contribution was significantly lower in the ICM than TE. It was also lower in the pTE than mTE and lower in the presumptive epiblast than presumptive hypoblast but neither of these differences was significant.
Apart from the epiblast-hypoblast difference at E4.5, the trends are consistent for the composition of E3.5 and E4.5 4n42nGFP and reciprocal 4nGFP42n chimeras when expressed relative to differences for the 2nGFP42n controls. These reflect a relative deficiency of 4n cells in the ICM compared to the TE, a relative deficiency in the pTE compared to the mTE and smaller relative deficiency in the presumptive epiblast compared to the presumptive hypoblast (Tables 1  and 2 ). Four of the six comparisons were statistically significant for the E3.5 chimeras but for the smaller group of E4.5 chimeras only one difference reached statistical significance. If 4n and 2n cells divided at the same rate and were randomly allocated among the 4 tissues 33% of cells should be 4n. However, at both E3.5 and E4.5 more 4n cells were present in the TE, specifically the mTE (Figs. 4D,F and  5D,F) . Overall the results imply that 4n cells are preferentially allocated to the TE rather than the ICM and within the TE they are preferentially allocated to the mTE. Within the ICM the 4n cells are somewhat depleted and tend to be preferentially allocated to the hypoblast rather than the epiblast.
The results from the quantitative analyses of the small groups of E5.5 and E7.5 blastocysts that had been maintained in diapause are shown in Fig. 6 . As discussed above, 4n cells were still present in the epiblast of many of these chimeras. At E5.5 the 4nGFP42n chimeras had a significantly higher percentage contribution of 4n cells in the TE than the ICM (Fig. 6B) , which is consistent with conclusions drawn for E3.5 and E4.5 4n42n chimeras. Only four 4nGFP42n chimeras Results for (a) are from were recovered at E7.5 and the mean contribution of 4n cells was quite low in all tissues but there were no significant differences between any of the pairwise comparisons.
The blastocyst cavity forms preferentially among 4n cells in 4n42n chimeras
As the 4n and 2n cells remain relatively unmixed in E3.5 4n42n chimeric blastocysts (Fig. 3B,C) the site where the blastocyst cavity forms may have a significant effect on the allocation of 4n cells to different tissues in the blastocyst. The blastocyst cavity is surrounded by the mTE and hypoblast which together comprise the abembryonic pole of the blastocyst (the epiblast and pTE comprise the embryonic pole). If the blastocyst cavity formed preferentially within the coherent cluster of 4n cells, 4n cells would be preferentially allocated to the mTE and hypoblast. To test whether the tissues at the abembryonic pole contained significantly more 4n cells than those at the embryonic pole, the percentage GFP-positive tissue was added for the two tissues at the embryonic pole (pTE plus epiblast) and subtracted from the sum of those at the abembryonic pole (mTE plus hypoblast) for each E3.5 chimera (Table 3) to derive an abembryonic GFP index. This index was significantly lower in the 4n42nGFP chimeras than the 2nGFP42n controls indicating a lower GFP (high 4n) contribution in the abembryonic region. The abembryonic GFP index was significantly greater in the 4nGFP42n chimeras than the 2nGFP42n controls, indicating a higher GFP (4n) contribution to the abembryonic region. This implies that 4n cells were significantly more abundant in the abembryonic region, surrounding the blastocyst cavity, in both reciprocal 4n42n chimera combinations at E3.5, suggesting that the blastocyst cavity forms preferentially within the coherent cluster of 4n cells in 4n42n chimeric aggregates.
Evidence for depletion of 4n cells during early development of 4nGFP42n chimeras
The compositions of chimeric blastocysts are compared at different ages for the two ICM derivatives (epiblast and hypoblast) in Fig. 7 and for the two trophectoderm-derivatives (pTE and mTE) in Fig. 8 . Initial comparison of the %GFP between E5.5 and E7.5 by Mann-Whitney U-tests showed no significant difference for any of the tissues of 4nGFP42n chimeric blastocysts and for the 2nGFP42n control chimeras only the hypoblast showed a significant difference (PZ0.03). Relatively few E5.5 and E7.5 chimeras were analysed so these were combined as a single age group (OE4.5) for the 4nGFP42n and 2nGFP42n control chimeras. (None of the 4n42nGFP chimeras were analysed at E5.5 or E7.5.) Although the variation in the composition of the hypoblast and mTE of the control 2nGFP42n chimeras causes some Results for (a) are from . Kruskal-Wallis tests showed no significant overall differences in percentage GFP with age for the epiblast but a significant difference for the hypoblast (PZ0.021). Pairwise comparisons with Mann-Whitney U-tests confirmed that there was no significant differences for the epiblast but the GFP contribution to the hypoblast declined significantly between E3.5 and OE4.5 (PZ0.003); it did not differ significantly for the individual intervals (E3.5-E4.5 and E4.5-OE4.5). (B) Composition of 4nGFP42n blastocysts at E3.5, E4.5 and OE4.5 (NZ23, 11 and 11 respectively). Kruskal-Wallis tests shows no significant overall differences in percentage 4n (GFP) with age for the epiblast but a significant difference for the hypoblast (PZ0.001). Pairwise comparisons with Mann-Whitney U-tests again showed no significant differences for the epiblast but the 4n (GFP) contribution to the hypoblast declined significantly between E3.5 and E4.5 (PZ0.003) and between E3.5 and OE4.5 (PZ0.001); it did not differ significantly between E4.5 and OE4.5. (C) Composition of 4n42nGFP blastocysts at E3.5 (NZ22) and E4.5 (NZ8). Mann-Whitney U-tests showed no significant differences in composition of the epiblast but the hypoblast showed a significant decline in 4n (non-GFP) contribution between E3.5 and E4.5 (PZ0.029).
uncertainty (Figs. 7A and 8A) , the results show that the contribution of 4n cells in 4n42n declined significantly in the hypoblast and mTE but not in the epiblast or pTE. For the hypoblast, the 4n contribution declined significantly between E3.5 and E4.5 in both 4nGFP42n and 4n42nGFP chimeras (Fig. 7B,C) . The later interval (between E4.5 and OE4.5) was not examined in 4n42nGFP chimeras and showed a small, non-significant decline in 4nGFP42n hypoblasts. For the mTE, the there was a significant decline in the 4nGFP42n chimeras between E3.5 and OE4.5 (Fig. 8B) , which differed from the controls (Fig. 8A ) in being more significant for the later interval. These results indicate that the contribution of 4n cells declines after the early blastocyst stage in both the inner cell mass and trophectoderm derivatives and that the most significant declines occur in the two abembryonic tissues (hypoblast and mTE) that were initially relatively enriched for 4n cells (see above).
Discussion
This study was designed to distinguish between the three hypotheses proposed to explain how 4n cells are excluded from the epiblast derivatives of mid-gestation 4n42n chimeras. The results support hypothesis 3 shown in Fig. 1 and indicate that a combination of non-random allocation of 4n cells to different developmental lineages and cell selection against 4n cells act to exclude 4n cells from the epiblast by mid-gestation. Fig. 9 summarises the mechanisms that act on the 4n cells in 4n42n chimeras and shows how they affect their fate in different developmental lineages. In agreement with previous studies of E3.5 4n42n chimeric blastocysts (Everett and West, 1996; Tang et al., 2000) , the quantitative analysis of E3.5 and E4.5 4n42n chimeras showed that 4n cells were preferentially allocated to the TE compared to the ICM and preferentially allocated to the mTE rather than the pTE. Our results also showed, for the first time, that more 4n ICM cells were allocated to the hypoblast than the epiblast. The 4n42n chimeric blastocysts maintained in a state of diapause confirmed that 4n cells were present within the differentiated epiblast region of late blastocysts. Absence of 4n cells from epiblast derivatives at later stages (James et al., 1995; Goto et al., 2002) must, therefore, imply subsequent loss of 4n cells from this lineage by some form of cell selection.
We now need to consider how non-random allocation and cell selection could occur. At the first allocation event 4n cells are preferentially allocated to the TE and so depleted from the ICM. Tang et al. (2000) previously demonstrated that larger 2n blastomeres make a greater contribution to the TE of 2n42n chimeras. Mechanical considerations might favour positioning larger cells outside the smaller ones, but it is not clear how much repositioning actually occurs in the aggregates. In any case, Tang et al. (2000) also demonstrated that 4n cells which did not differ in size from the cells of the partner 2n embryos, also made a significantly greater contribution to the mTE. Thus, cell size is probably not solely responsible for the preferential allocation of cells to the TE. When the 8-cell stage embryo compacts, its cells become polarised and during the next two cell divisions these cells can divide either conservatively to form two polarised cells or differentiatively to produce one polarised cell and one apolar cell. The polarised cells form the TE and the inner apolar cells form the ICM so that allocation of cells of the morula to the ICM or TE depends on the type of division. The number of conservative and differentiative divisions can vary as the embryo divides from 8 to 16 and from 16 to 32 cells but the proportions of ICM and TE cells vary less by the 32 cell stage (Fleming, 1987) . It is not clear how 4n cells in a 4n42n chimeric morula are preferentially allocated to the trophectoderm rather than the ICM at the first allocation event but if 4n cells have a higher probability of dividing conservatively most of their progeny would be fated to become TE rather than ICM.
Non-random allocation of 4n and 2n cells at the next two allocation events seems likely to be mediated via preferential formation of the blastocyst cavity in the coherent group of 4n cells in the 4n42n chimeric morula. Everett et al. (2000) previously suggested this possibility but it could not be tested (NZ21, 8 and 12 respectively) . Kruskal-Wallis tests showed no significant overall differences in percentage GFP with age for the pTE but a significant difference for the mTE (PZ0.006). Pairwise comparisons with MannWhitney U-tests confirmed that there were no significant differences for the pTE. The GFP contribution to the mTE declined significantly between E3.5 and OE4.5 (PZ0.003) but the decline for the two smaller time intervals was less significant (PZ0.045 between E3.5 and E4.5 and not significant between E4.5 and OE4.5). (B) Composition of 4nGFP42n blastocysts at E3.5, E4.5 and OE4.5 (NZ23, 11 and 11 respectively). Kruskal-Wallis tests shows no significant overall differences in percentage 4n (GFP) with age for the pTE but a highly significant difference for the mTE (PZ0.0002). Pairwise comparisons with Mann-Whitney U-tests again showed no significant differences for the pTE but the 4n (GFP) contribution to the mTE declined significantly between E3.5 and OE4.5 (PZ0.0001) and between E4.5 and OE4.5 (PZ0.011); it did not differ significantly between E3.5 and E4.5. (C) Composition of 4n42nGFP blastocysts at E3.5 (NZ22) and E4.5 (NZ8). Mann-Whitney U-tests showed no significant differences in contribution of 4n cells (non-GFP) to the pTE or mTE between E3.5 and E4.5.
adequately with the DNA in situ marker that was used in their study. Once the cavity has formed this defines the region of TE adjacent to the cavity as mTE and the TE cells overlying the ICM as pTE. The observed tendency of the blastocyst cavity to form within the group of 4n cells will ensure that the second and third allocation events are non-random, with more 4n cells initially allocated to the mTE than the pTE and more allocated to the hypoblast than epiblast. Although the third allocation Fig. 9 . Diagrammatic summary of the fate of 4n cells in 4 developmental lineages (epiblast, hypoblast, polar trophectoderm and mural trophectoderm) after aggregation of 8-cell stage diploid embryos (white) with 4-cell stage tetraploid embryos (black). The fate of 4n cells is deduced from the combined results of the present study and previous work (James et al., 1995; Everett and West, 1996; Everett and West, 1998; Goto et al., 2002) . Each tissue is represented by a rectangle, shaded to represent the level of 4n contribution and showing the approximate percentage 4n contribution at the blastocyst and peri-implantation stages. These are based on estimates of GFP-positive tissue in the present study but have not been converted to the % 4n cells. The blastocyst values are rounded means for E3.5 blastocysts in Fig. 4C ,E and the peri-implantation values are overall estimates based on the E4.5 and OE4.5 blastocysts in Figs. 5C,E and 6B,D (see below). The present study shows that tetraploid cells are present in all four tissues at the blastocyst stage (including the epiblast) but 4 steps were identified which affect the 4n contributions to different lineages. Quantitative analysis of E3.5 blastocysts suggests that few 4n cells are allocated to the inner cell mass (ICM) than the trophectoderm (step 1) and fewer 4n cells are allocated to the tissues in the embryonic half (epiblast and pTE) than the abembryonic half (hypoblast and mTE) of the blastocyst (step 2). Analysis of E4.5 and OE4.5 blastocysts indicate that 4n cells are then depleted (mostly in the hypoblast and mTE; step 3) but most late blastocyst stage 4n42n chimeras probably retain some 4n cells in all four lineages at the time of implantation. By the postimplantation E7.5 stage 4n cells are depleted in the epiblast (step 4) but it is uncertain whether they are completely excluded by this stage (Goto et al., 2002; James et al., 1995) . By E12.5 tetraploid cells are excluded from the epiblast lineage (the fetus and extraembryonic epiblast derivatives) but some still contribute to the polar trophectoderm and hypoblast derivatives. The mural trophectoderm stops dividing early in development and so contributes little to the postimplantation conceptus. Abbreviations: YS endoderm, visceral yolk sac endoderm; P endoderm, parietal endoderm. event (separating epiblast and hypoblast) occurs about 24 h later it is still affected by the location of the blastocyst cavity because the 4n and 2n cells remain unmixed and spatially separated (Fig. 3A-D and previous studies: Garner and McLaren, 1974; Dvorak et al., 1995; Gardner and Cockroft, 1998; Everett et al., 2000) .
Distribution of tetraploid cells in chimeric lineages
Previous analysis of 4n42n chimeric blastocysts showed a reduction in 4n cells in both the ICM and TE between E3.5 and E4.5 (Everett and West, 1998) but those E4.5 embryos were cultured for approximately 6 h longer than the E4.5 blastocysts in the present study and so were likely to be more advanced. We found a reduction in 4n cells in both the ICM and TE (specifically hypoblast and mTE) either between E3.5 and E4.5 (hypoblast) or between E4.5 and OE4.5 (mTE) but there was no convincing evidence of selection against 4n cells in the epiblast or pTE. The mTE stops proliferating and as the blastocyst enlarges it is supplemented with cells from the more proliferative pTE region (Copp, 1978; 1979) and this may contribute to the depletion of 4n cells in the mTE. It seems likely that cell selection depletes the contribution of 4n cells after the blastocyst implants into the uterus and may be essentially complete in the E7.5 postimplantation stage embryo (James et al., 1995) or shortly afterwards (Goto et al., 2002) . Both studies agree that 4n cells are almost always eliminated from the epiblast by E12.5. There have been cases of 4n cells surviving in the epiblast derivatives of 4n42n chimeras beyond mid-gestation but these chimeras were produced by using a higher proportion of 4n cells at aggregation (Lu and Markert, 1980; Goto and Takagi, 1998; Tarkowski et al., 2001; Goto et al., 2002) . While 4n cells are usually excluded from the epiblast of 4n42n chimeras produced in the standard way (by aggregating one 4-cell tetraploid embryo with one 8-cell diploid embryo) a higher initial proportion of 4n cells may not always be eliminated. Similarly, variation in the 4n contribution to E7.5 postimplantation chimeras (James et al., 1995; Goto et al., 2002 ) may reflect differences in the proportion of 4n cells initially allocated to the epiblast and this could be partly strain-dependent.
It is not known how the selection against 4n cells in the epiblast cells between late blastocyst and mid-gestation acts. Selection in a chimera may involve competition between 4n and 2n cells. For example, if 4n cells proliferated more slowly they could become diluted or lost but it is not known whether such a difference exists (Henery and Kaufman (1991) and unpublished data cited in Goto et al. (2002) ) or whether it would be sufficient to eliminate 4n cells from the epiblast by mid-gestation. Goto et al. (2002) suggest instead that 4n cells may be less competent in differentiating into some cell types. This is supported by the observations that non-chimeric tetraploid mouse embryos usually fail to produce organised embryos after implantation (Tarkowski et al., 1977; James et al., 1992) but not by a few reports of tetraploid mouse embryos developing to late fetal stages (Snow, 1975; Kaufman and Webb, 1990; Kaufman, 1991) . Polyploid cells accumulate in some differentiated tissues including placental trophoblast (Brodsky and Uryvaeva, 1977; Klisch et al., 1999 ) so they might be tolerated better in terminally differentiated extraembryonic tissues than in embryonic tissues which are still not fully differentiated. However, this does not explain why 4n cells are eliminated from the whole of the epiblast lineage (extraembryonic tissues as well as the fetus) but not from the trophectoderm or hypoblast. As discussed previously (James et al., 1995) a final selection step might be death of a few chimeric conceptuses with high levels of 4n cells in the epiblast.
Preimplantation embryos of pigs (Long and Williams, 1982) , sheep (Murray et al., 1986) , cattle (Hare et al., 1980; Kawarsky et al., 1996; Viuff et al., 1999) and humans West et al., 1987; Harper et al., 1995; Harrison et al., 2000; Wells and Delhanty, 2000) frequently contain polyploid cells. Viuff et al. (2002) showed that polyploid cells in polyploidy/diploid mosaic bovine embryos were more abundant in the trophectoderm than embryonic disc and declined in frequency in both lineages between days 7 and 12. There are obvious parallels between these naturally occurring bovine polyploid/diploid mosaics and experimental 4n42n mouse chimeras but it is not known whether the mechanisms by which 4n cells are depleted are similar.
If similar parallels exist with the naturally occurring human polyploidy/diploid mosaic embryos this may help explain how some types of human confined placental mosaicism (CPM) arise, where chromosomally abnormal cells are confined to the cytotrophoblast. Although human CPM usually involves trisomy/diploid mosaicism, tetraploid/diploid CPM also occurs (Edwards et al., 1994) . Previous results from mouse 4n42n chimeras have influenced the interpretation of clinical data (Kalousek and Vekemans, 1996; Wolstenholme, 1996) and the mechanisms reported here could be equally relevant. Although Derhaag et al. (2003) showed that chromosomally abnormal cells were not preferentially allocated to the trophectoderm rather than the inner cell mass of human preimplantation embryos, few of the abnormalities involved polyploidy (five embryos analysed by FISH for three chromosomes were tetrasomic or tetraploid mosaics) and it has not yet been possible to investigate the epiblast and hypoblast separately.
The evidence, that 4n cells initially contribute to the epiblast lineage and may survive until early postimplantation stages, may be relevant to the interpretation of results of some tetraploid complementation studies designed to identify whether gene action occurs in the epiblast (Section 1). In these studies, survival of diploid mutant fetuses is usually assumed to represent rescue by wildtype 4n cells in the trophectoderm and/or hypoblast lineages implying that wildtype gene expression is not required in the epiblast lineage. However, we have now shown that 4n cells survive in the early epiblast, so fetal survival could also be mediated by the presence of 4n cells expressing the wildtype allele of a gene that is required in the epiblast only at an early stage. This problem may be more significant if more than one 4-cell tetraploid embryo is used to produce each chimera because the number of 4n cells in the epiblast will be increased and they will be retained for longer (Goto et al., 2002) . Even if the fetus and other epiblast tissues have no 4n cells at the time of analysis this does not preclude the presence of 4n cells at an earlier stage. This possibility should not be overlooked when interpreting tetraploid complementation experiments.
Experimental procedures

Mouse strains
For the experiments reported here, hemizygous TgTP6.3 C/K transgenic mice (Pratt et al., 2000; MacKay et al., 2005) were selected and maintained by crossing to (C57BL/6/Ola! CBA/Ca)F 1 hybrid ('BF 1 ') mice. This 'TP6.3' stock was made homozygous for Gpi1 b and hemizygous for the TgTP6.3 tauGFP transgene. Mice used as embryo recipients were F 1 hybrids ('CF 1 ') of two strains, which were homozygous for Tyr c (formerly c) and Gpi1 c , and partially congenic on C57BL/6 and BALB/c genetic backgrounds respectively (West and Flockhart, 1994) . The (C57BL/6/Ola!CBA/Ca)F 1 hybrid ('BF 1 ') female mice were purchased from the Anne Walker animal facility, University of Edinburgh. All other animals were bred and maintained in the Medical Faculty Animal Area, University of Edinburgh, with a light cycle of 14 h light (05:00-19:00 h) and 10 h dark (19:00-05:00 h).
Superovulation and embryo collection
Adult female mice were superovulated by intraperitoneal injections of 5 I.U. PMSG (pregnant mare's serum gonadotrophin; Folligon, Intervet) at midday, followed by 5 I.U. hCG (human chorionic gonadotrophin; Chorulon, Intervet) 48 h later. The females were mated individually to males, and checked for the presence of a vaginal plug the following morning (designated 0.5 days post coitum). Plugged females were sacrificed by cervical dislocation at 1.5 days for the collection of 2-cell embryos (embryonic day 1.5; E1.5). 2-cell embryos were flushed from the oviducts. Embryos were subsequently washed and kept in KSOM-H handling medium (Summers et al., 1995) before use.
Production of tetraploid embryos by electrofusion
1-cell tetraploid embryos were produced by fusing the cells of 2-cell diploid embryos, using a CF-150 impulse generator and GPT-250 electrode chamber (BLS Ltd, Biological Laboratory Equipment, Budapest). 2-cell embryos were flushed and collected in KSOM-H handling medium. The embryos were washed in a drop of 3 M mannitol then placed between the electrodes of the electrofusion chamber containing 200 ml of electrofusion medium (0.3 M mannitol, 0.1 mM MgSO 4 , 0.05 mM CaCl 2 and 0.05 mg/ml BSA). An AC pulse of 5 V was applied for 5 s to align the embryos, followed by a DC pulse of 20 V for 80 ms to degrade the cell membrane and therefore cause cell fusion. Embryos were subsequently washed in fresh KSOM-H medium four times, using clean pipettes to avoid contamination with mannitol, and transferred to pre-equilibrated KSOM culture medium (Lawitts and Biggers, 1993; Erbach et al., 1994) under silicon oil (BDH) in a 37 8C, 5% CO 2 in air incubator. Embryos with fused blastomeres were selected 15-30 min later and cultured overnight in KSOM medium to the 4-cell stage for aggregation.
Production of chimeras by embryo aggregation
Three groups of (BF 1 !TP6.3)4(BALB/c!A/J)F 2 chimeras were produced for these experiments. For the two reciprocal experimental chimera series (4nGFP42n and 4n42nGFP), 2-cell embryos of one genotype were electrofused (to produce 1-cell tetraploid embryos) and embryos of both genotypes (1-cell tetraploid and 2-cell diploid) were cultured overnight before aggregation. After culture, four-cell tetraploid (BF 1 !TP6.3) embryos were aggregated to 8-cell diploid (BALB/c!A/J)F 2 embryos, and, in the reciprocal combination, 8-cell diploid (BF 1 !TP6.3) embryos were aggregated to 4-cell tetraploid (BALB/c!A/J)F 2 embryos. The 2nGFP42n control series of (BF 1 !TP6.3)4(BALB/c! A/J)F 2 chimeras was made by aggregating 8-cell diploid embryos that had been collected at the 2-cell stage and cultured overnight. Aggregation chimeras were produced by our standard procedure, involving aggregation of pairs of zonafree embryos (West and Flockhart, 1994) , which is based on the original method of Tarkowski (1961) . Pairs of zona-free embryos were pushed together in individual drops of medium containing one part of phytohaemagglutinin (PHA, M-form, Gibco, 10576-015) and 19 parts KSOM-H handling medium (Mintz et al., 1973; Pratt, 1987) . After a few minutes, aggregates were washed in KSOM-H handling medium, transferred to KSOM culture medium under silicon oil (BDH) and cultured for approximately 24 or 48 h in a 37 8C, 5% CO 2 in air incubator for analysis at E3.5 or E4.5, or surgical transfer to a pseudopregnant recipient at E3.5.
Embryo transfer to maintain blastocysts in diapause
Recipient females were mated to vasectomised males and on 2.5 days of pseudopregnancy they were anaesthetised with Hypnorm and Hypnovel and 8-10 E3.5 chimeras were transferred to each uterine horn. Following embryo transfer each female was injected with 10 mg (i.p.) Tamoxifen (Sigma) and with 1 mg (s.c.) Depoprovera (Genus Express), as described in Hunter and Evans (1999) . Blastocysts were staged according to the age of the embryo, rather than the stage of pseudopregnancy.
Confocal microscopy of living chimeric blastocysts
Chimeras that had been cultured in vitro or flushed from tamoxifen-treated females were transferred to fresh drops of KSOM culture medium under silicon oil (BDH) in a glass bottomed Willco microwell dish (Intracel Ltd, HBSt 3522). These were kept in a 37 8C, 5% CO 2 in air incubator for at least 3 h prior to imaging, to ensure that the blastocyst cavity re-expanded if it had collapsed after pipetting. The blastocysts were imaged on the heated stage of the inverted confocal microscope. Images were taken with a Leica TCS NT confocal system attached to a Leica DMIRBE inverted microscope.
Analysis of chimeras
The percentage contribution of GFP-positive cells to chimeric embryos was analysed in selected mid section confocal images of GFP overlain on bright field images, using Image Pro Plus software (Media Cybernetics, MD, USA). The epiblast and hypoblast could not be distinguished clearly in E3.5 blastocysts that have been cultured in vitro. However, the position of cells within the ICM determines the fate of these cells, so the cells adjacent to the blastocyst cavity usually develop into hypoblast cells and cells adjacent to the pTE normally develop into epiblast cells (Weber et al., 1999; Ciemerych et al., 2000; Piotrowska and Zernicka-Goetz, 2001 ). The presumptive epiblast and presumptive hypoblast regions were defined by drawing a line halfway across the ICM, as shown in Fig. 2 . The lengths of GFP-positive and GFP-negative pTE and mTE tissue were measured around the circumference (Fig. 2B ) and expressed as a percentage GFP-positive tissue. The areas of GFP-positive and GFP-negative epiblast and hypoblast tissue were measured (Fig. 2C ) and expressed as a percentage GFP-positive tissue.
The 4n42n chimeras were analysed by measuring the % GFP-positive and negative areas in the ICM, presumptive epiblast and presumptive hypoblast and the % GFP-positive and negative lengths in the TE, mTE and pTE. This estimate of the percentage contribution of 4n cells to the different regions of the blastocyst is not equivalent to the percentage of 4n cells because 4n and 2n cells differ in size. The 4n embryos used in this study were produced by the fusion of the two cells in a 2-cell embryo, so each 4n blastomere is initially twice the volume of a 2n blastomere. The predicted differences in area (1.59-fold) and length (1.26-fold) for spheres that differ twofold in volume were used to estimate percentages of 4n cell numbers from observed percentages of areas or lengths of 4n tissue.
